Structure Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Hall Ashley | Chief Development Officer | Tax Withholding | 6,021 | $7.74 | $46,603 | 112,317 | Sep 18, 2025 |
| Coll Crespo Blas | CHIEF MEDICAL OFFICER | Tax Withholding | 8,106 | $7.74 | $62,740 | 216,807 | Sep 18, 2025 |
| Ma Yingli | CHIEF TECHNOLOGY OFFICER | Tax Withholding | 4,470 | $6.84 | $30,575 | 118,704 | Jul 1, 2025 |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | Tax Withholding | 12,846 | $6.84 | $87,867 | 204,327 | Jul 1, 2025 |
| Coll Crespo Blas | CHIEF MEDICAL OFFICER | Tax Withholding | 1,233 | $7.92 | $9,765 | 218,355 | Jul 1, 2025 |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | Tax Withholding | 6,441 | $7.92 | $51,013 | 160,095 | Jul 1, 2025 |
| Yoon Jun | CHIEF FINANCIAL OFFICER | Tax Withholding | 5,940 | $7.92 | $47,045 | 1,287,359 | Jul 1, 2025 |
| Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Tax Withholding | 12,495 | $7.92 | $98,960 | 1,121,183 | Jul 1, 2025 |
| Coll Crespo Blas | Chief Medical Officer | Award / Grant | 116,988 | — | — | 219,588 | Mar 15, 2025 |
| Hall Ashley | Chief Development Officer | Award / Grant | 51,048 | — | — | 118,338 | Mar 15, 2025 |
| Ma Yingli | CHIEF TECHNOLOGY OFFICER | Award / Grant | 63,810 | — | — | 100,539 | Mar 15, 2025 |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | Award / Grant | 80,829 | — | — | 166,536 | Mar 15, 2025 |
| Yoon Jun | CHIEF FINANCIAL OFFICER | Award / Grant | 170,166 | — | — | 1,293,299 | Mar 15, 2025 |
| Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Award / Grant | 340,332 | — | — | 1,133,678 | Mar 15, 2025 |
| Ma Yingli | CHIEF TECHNOLOGY OFFICER | Award / Grant | 24,459 | — | — | 123,174 | Mar 1, 2025 |
| Hall Ashley | Chief Development Officer | Award / Grant | 67,290 | — | — | 67,290 | Sep 18, 2024 |
| Coll Crespo Blas | Chief Medical Officer | Award / Grant | 90,600 | — | — | 102,600 | Sep 18, 2024 |
| Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Option Exercise | 99,999 | $0.39 | $39,000 | 743,345 | Jun 12, 2024 |
| Stevens Raymond C | CHIEF EXECUTIVE OFFICER | C | 555,000 | — | — | 643,346 | Jun 10, 2024 |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | C | 106,200 | — | — | 85,707 | Jun 3, 2024 |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | Award / Grant | 85,707 | — | — | 85,707 | Mar 15, 2024 |
| Ma Yingli | CHIEF TECHNOLOGY OFFICER | Award / Grant | 36,729 | — | — | 36,729 | Mar 15, 2024 |
| Bach Mark Allen | CHIEF MEDICAL OFFICER | Award / Grant | 26,235 | — | — | 26,235 | Mar 15, 2024 |
| Yoon Jun | CHIEF FINANCIAL OFFICER | Award / Grant | 59,469 | — | — | 1,123,133 | Mar 15, 2024 |
| Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Award / Grant | 134,682 | — | — | 1,198,346 | Mar 15, 2024 |
| BIOTECHNOLOGY VALUE FUND L P | — | Other | 2,929,660 | — | — | — | May 10, 2023 |
| WELCH DANIEL G | — | C | 123,508 | — | — | 123,508 | Feb 7, 2023 |
| Farid Ramy | — | C | 642,245 | — | — | 3,260,495 | Feb 7, 2023 |
| FMR LLC | — | C | 57,523 | — | — | 57,523 | Feb 7, 2023 |
| FIL Ltd | — | C | 494,035 | — | — | 494,035 | Feb 7, 2023 |